[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neuropace Inc (NPCE)

Neuropace Inc (NPCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 533,230
  • Shares Outstanding, K 34,094
  • Annual Sales, $ 99,990 K
  • Annual Income, $ -21,470 K
  • EBIT $ -17 M
  • EBITDA $ -15 M
  • 60-Month Beta 1.88
  • Price/Sales 5.40
  • Price/Cash Flow N/A
  • Price/Book 36.90

Options Overview Details

View History
  • Implied Volatility 80.05% (-6.44%)
  • Historical Volatility 63.08%
  • IV Percentile 6%
  • IV Rank 15.02%
  • IV High 247.30% on 11/14/25
  • IV Low 50.49% on 05/28/26
  • Expected Move (DTE 5) 0.00 (0.00%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 18
  • Put/Call OI Ratio 0.45
  • Today's Open Interest 343
  • Open Int (30-Day) 370
  • Expected Range 15.64 to 15.64

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.19
  • Number of Estimates 2
  • High Estimate $-0.16
  • Low Estimate $-0.21
  • Prior Year $-0.26
  • Growth Rate Est. (year over year) +26.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.65 +14.58%
on 05/13/26
17.65 -11.39%
on 05/29/26
-0.16 (-1.01%)
since 05/12/26
3-Month
12.47 +25.42%
on 03/31/26
19.60 -20.20%
on 05/08/26
+1.52 (+10.76%)
since 03/12/26
52-Week
7.56 +106.81%
on 08/13/25
19.60 -20.20%
on 05/08/26
+4.41 (+39.27%)
since 06/12/25

Most Recent Stories

More News
NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting

-- ASSFN program to feature thalamic neuromodulation, NAUTILUS data in idiopathic generalized epilepsy, and emerging applications for broader epilepsy populations-- ...

NPCE : 15.64 (-1.26%)
NeuroPace Announces FDA Approval of ECoG Assistantâ„¢, Advancing AI-Driven Epilepsy Care

-- First in a suite of planned NeuroPace AI tools designed to deliver deeper data insights, support clinical outcomes and further enhance efficiency of RNS therapy --

NPCE : 15.64 (-1.26%)
NeuroPace Q1 Earnings Call Highlights

NeuroPace (NASDAQ:NPCE) raised its 2026 revenue outlook after reporting first-quarter results that management said reflected continued demand for its RNS System and improving commercial execution across...

NPCE : 15.64 (-1.26%)
NeuroPace Inc.: Q1 Earnings Snapshot

NeuroPace Inc.: Q1 Earnings Snapshot

NPCE : 15.64 (-1.26%)
NeuroPace Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Guidance

--Total revenue of $22.1 million-- -- Raises full year 2026 guidance to $99 million to $101 million, up from $98 million to $100 million previously-- ...

NPCE : 15.64 (-1.26%)
NeuroPace to Report First Quarter 2026 Financial Results on May 12, 2026

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the first quarter of 2026...

NPCE : 15.64 (-1.26%)
NeuroPace Highlights Expanding Clinical Evidence Leadership with Published 3-Year Post-Approval Study (PAS) Results in Neurology and NAUTILUS Presentation at AAN 2026

— Published 3-year Post-Approval Study results show 82% median seizure reduction in drug-resistant focal epilepsy — — American...

NPCE : 15.64 (-1.26%)
NeuroPace to Present at the 25th Annual Needham Virtual Healthcare Conference

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the 25 th ...

NPCE : 15.64 (-1.26%)
NeuroPace to Present at the Leerink Global Healthcare Conference

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the Leerink 2026 Global...

NPCE : 15.64 (-1.26%)
NeuroPace Inc.: Q4 Earnings Snapshot

NeuroPace Inc.: Q4 Earnings Snapshot

NPCE : 15.64 (-1.26%)

Business Summary

NeuroPace Inc. is a commercial-stage medical device company. It is focused on developing products to treat and transform the lives of patients suffering from epilepsy. NeuroPace Inc. is based in MOUNTAIN VIEW, Calif.

See More

Key Turning Points

3rd Resistance Point 16.23
2nd Resistance Point 16.10
1st Resistance Point 15.87
Last Price 15.64
1st Support Level 15.52
2nd Support Level 15.39
3rd Support Level 15.16

See More

52-Week High 19.60
Last Price 15.64
Fibonacci 61.8% 15.00
Fibonacci 50% 13.58
Fibonacci 38.2% 12.16
52-Week Low 7.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.